These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2261943)

  • 21. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
    Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Drugs; 1992; 44 Suppl 1():74-84. PubMed ID: 1283588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
    Ueda Y; Aoi W; Yamachika S; Shikaya T
    Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
    J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enalapril and verapamil in the treatment of isolated systolic hypertension in the elderly.
    Espinel CH; Bruner DE; Davis JR; Williams JL
    Clin Ther; 1992; 14(6):835-44. PubMed ID: 1286492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of verapamil in hypertensive patients.
    de Leeuw PW; Birkenhäger WH
    Acta Med Scand Suppl; 1984; 681():125-8. PubMed ID: 6375284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular pressor responses in treated and untreated essential hypertension.
    Donnelly R; Elliott HL; Howie CA; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):191-6. PubMed ID: 1697373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal response to amino acid infusion in essential hypertension.
    Juncos L; Cornejo JC; Pamies-Andreu E; Romero JC
    Hypertension; 1994 Jan; 23(1 Suppl):I225-30. PubMed ID: 8282364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
    Di Somma S; Carotenuto A; de Divitiis M; Paulucci A; Galderisi M; Cuocolo A; de Divitiis O
    J Hum Hypertens; 1995 Mar; 9(3):163-8. PubMed ID: 7783096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Billaud-Mesguish E; Alexandre JM
    Gerontology; 1987; 33 Suppl 1():9-16. PubMed ID: 2831117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.